A novel ERK1/2 inhibitor has potent activity in KRAS-mutant non-small cell lung cancer models

被引：0

作者：

Courtin, Aurelie ^{[1
]}

Bevan, Luke ^{[1
]}

Heightman, Tom ^{[1
]}

Kidane, Birikiti ^{[1
]}

Kucia-Tran, Justyna ^{[1
]}

Lyons, John ^{[1
]}

Muench, Sandra ^{[1
]}

Shah, Alpesh ^{[1
]}

Stanczuk, Lukas ^{[1
]}

Thompson, Neil ^{[1
]}

Wallis, Nicola ^{[1
]}

Wilsher, Nicola ^{[1
]}

Munck, Joanne ^{[1
]}

机构：

[1] Astex Pharmaceut, Cambridge, England

来源：

CANCER RESEARCH | 2018年 / 78卷 / 13期

关键词：

D O I：

10.1158/1538-7445.AM2018-5781

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

5781

引用

页数：2

共 50 条

[1] Evaluating Racial Differences in KRAS-Mutant Non-Small Cell Lung Cancer
Aredo, J.
Padda, S.
Kunder, C.
Han, S.
Wakelee, H.
[J]. JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (11) : S1133 - S1133
[2] KRAS-Mutant non-small cell lung cancer: From biology to therapy
Ferrer, Irene
Zugazagoitia, Jon
Herbertz, Stephan
John, William
Paz-Ares, Luis
Schmid-Bindert, Gerald
[J]. LUNG CANCER, 2018, 124 : 53 - 64
[3] Targeting KRAS-mutant non-small cell lung cancer: challenges and opportunities
Zhang, Jun
Park, Dongkyoo
Shin, Dong M.
Deng, Xingming
[J]. ACTA BIOCHIMICA ET BIOPHYSICA SINICA, 2016, 48 (01) : 11 - 16
[4] Targeting KRAS-Mutant Non-Small Cell Lung Cancer with the Hsp90 Inhibitor Ganetespib
Acquaviva, Jaime
Smith, Donald L.
Sang, Jim
Friedland, Julie C.
He, Suqin
Sequeira, Manuel
Zhang, Chaohua
Wada, Yumiko
Proia, David A.
[J]. MOLECULAR CANCER THERAPEUTICS, 2012, 11 (12) : 2633 - 2643
[5] Combination of an ERK1/2 inhibitor (LY3214996) with VEGFR-2 inhibitor enhances anti-tumor activity in KRAS mutant non-small cell lung cancer
Wu, Wenjuan
Bhagwat, Shripad V.
Jones, Bonita D.
Swearingen, Michelle L.
Falcon, Beverly L.
McMillen, William T.
Joseph, Sajan
Buchanan, Sean
Peng, Sheng-Bin
Reinhard, Christoph
Tiu, Ramon V.
[J]. CANCER RESEARCH, 2018, 78 (13)
[6] SHP2 inhibitor specifically suppresses the sternness of KRAS-mutant non-small cell lung cancer cells
Jiang, Lei
Xu, Weiping
Chen, Yi
Zhang, Yue
[J]. ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY, 2019, 47 (01) : 3231 - 3238
[7] Management of KRAS-Mutant Non-Small Cell Lung Cancer in the Era of Precision Medicine
Jacqueline V. Aredo
Sukhmani K. Padda
[J]. Current Treatment Options in Oncology, 2018, 19
[8] Identification of a targetable KRAS-mutant epithelial population in non-small cell lung cancer
Giorgia Maroni
Mahmoud A. Bassal
Indira Krishnan
Chee Wai Fhu
Virginia Savova
Rapolas Zilionis
Valerie A. Maymi
Nicole Pandell
Eva Csizmadia
Junyan Zhang
Barbara Storti
Julio Castaño
Riccardo Panella
Jia Li
Corinne E. Gustafson
Sam Fox
Rachel D. Levy
Claire V. Meyerovitz
Peter J. Tramontozzi
Kimberly Vermilya
Assunta De Rienzo
Stefania Crucitta
Daniela S. Bassères
Marla Weetall
Art Branstrom
Alessandra Giorgetti
Raffaele Ciampi
Marzia Del Re
Romano Danesi
Ranieri Bizzarri
Henry Yang
Olivier Kocher
Allon M. Klein
Robert S. Welner
Raphael Bueno
Maria Cristina Magli
John G. Clohessy
Azhar Ali
Daniel G. Tenen
Elena Levantini
[J]. Communications Biology, 4
[9] Identification of a targetable KRAS-mutant epithelial population in non-small cell lung cancer
Maroni, Giorgia
Bassal, Mahmoud A.
Krishnan, Indira
Fhu, Chee Wai
Savova, Virginia
Zilionis, Rapolas
Maymi, Valerie A.
Pandell, Nicole
Csizmadia, Eva
Zhang, Junyan
Storti, Barbara
Castano, Julio
Panella, Riccardo
Li, Jia
Gustafson, Corinne E.
Fox, Sam
Levy, Rachel D.
Meyerovitz, Claire, V
Tramontozzi, Peter J.
Vermilya, Kimberly
De Rienzo, Assunta
Crucitta, Stefania
Basseres, Daniela S.
Weetall, Marla
Branstrom, Art
Giorgetti, Alessandra
Ciampi, Raffaele
Del Re, Marzia
Danesi, Romano
Bizzarri, Ranieri
Yang, Henry
Kocher, Olivier
Klein, Allon M.
Welner, Robert S.
Bueno, Raphael
Magli, Maria Cristina
Clohessy, John G.
Ali, Azhar
Tenen, Daniel G.
Levantini, Elena
[J]. COMMUNICATIONS BIOLOGY, 2021, 4 (01)
[10] Management of KRAS-Mutant Non-Small Cell Lung Cancer in the Era of Precision Medicine
Aredo, Jacqueline V.
Padda, Sukhmani K.
[J]. CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2018, 19 (08)

← 1 2 3 4 5 →